je.st
news
Tag: fourthquarter
PepsiCo Stock Should Remain Bubbly Ahead of Fourth-Quarter Earnings
2015-02-09 19:37:00| Beverages - Topix.net
NEW YORK -- The world may be drinking less soda on average, but profits at beverage and snack food giant PepsiCo , Pepsi's diversified business model has become an asset . Investors looking for revenue and earnings growth have invested in the right stock.
Tags: stock
remain
ahead
earnings
PepsiCo Stock Should Remain Bubbly Ahead of Fourth-Quarter Earnings
2015-02-09 19:36:59| Beverages - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tags: stock
remain
ahead
earnings
Clean Harbors to Announce Fourth-Quarter 2014 Financial Results on February 25
2015-02-09 15:33:15| Waste Management - Topix.net
On the call, Chairman and Chief Executive Officer Alan S. McKim and Vice Chairman, President and Chief Financial Officer James M. Rutledge will discuss Clean Harbors' financial results, business outlook and growth strategy. Those who wish to listen to the fourth-quarter 2014 conference call webcast should visit the Investor Relations section of the Company's website at www.cleanharbors.com .
Tags: results
february
financial
clean
Investors Should Milk Dean Foods for Profits Ahead of Fourth-Quarter Earnings
2015-02-09 15:08:24| Food - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Merck Announces Fourth-Quarter and Full-Year 2014 Financial Results
2015-02-04 13:02:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Fourth-Quarter 2014 Non-GAAP EPS of $0.87, Excluding Certain Items; GAAP EPS of $2.54; Full-Year 2014 Non-GAAP EPS of $3.49, Excluding Certain Items; GAAP EPS of $4.07 2015 Full-Year Non-GAAP EPS Target of $3.32 to $3.47, Including a $0.27 Negative Impact From Foreign Exchange and Excluding Certain Items; GAAP EPS Range of $1.62 to $1.91 Fourth-Quarter 2014 Worldwide Sales of $10.5 Billion, a Decrease of 7 Percent, Reflecting Unfavorable Impact of Patent Expiries and Divestitures and a 3 Percent Negative Impact From Foreign Exchange Full-Year 2014 Worldwide Sales of $42.2 Billion, a Decrease of 4 Percent, Reflecting Unfavorable Impact of Patent Expiries and Divestitures and a 1 Percent Negative Impact From Foreign Exchange Full-Year Results Reflect Sales Growth in Immunology, Diabetes, Hospital Acute Care, Vaccines and Animal Health and Sales Declines in Hepatitis C Six New Products Were Approved in the United States in 2014; Company Accelerated KEYTRUDA and Hepatitis C Clinical Development Programs KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2014. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestors:Justin Holko, 908-740-1879Joe Romanelli, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »